Retroperitoneal sarcomas

1.Mettlin C, Priore R, Rao U. Results of the national soft tissue sarcoma registry. J Surg Oncol.1982; 19 :224–7. [PubMed]

2.McGrath P. Retroperitoneal sarcomas. Semin Surg Oncol.1994; 10 :364–8. [PubMed]

3.Daugaard S. Current soft tissue sarcoma classification. Eur J Cancer.2004; 40 :543–8. [PubMed]

4.Coindre JM, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytomas. Mod Pathol.2003; 16 :256–62. [PubMed]

5.Papanicolaou N, Yoder IC, Lee MJ. Primary retroperitoneal neoplasms: How close can we come in making the correct diagnosis. Urol Radiol.1992; 14 :221–8. [PubMed]

6.Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft tissue sarcoma. Ann Surg.1995; 221 :185–95. [PMC free article] [PubMed]

7.van Dalus T, van Geel AN, van Coevorden F, et al. Dutch soft tissue sarcoma group. Soft tissue carcinoma in the retroperitoneum: an often-neglected diagnosis. Eur J Surg Oncol.2001; 27 :74–9. [PubMed]

8.Arca MJ, Sondak VK, Chang AE. Diagnostic procedures and pretreatment evaluation of soft tissue sarcomas. Semin Surg Oncol.1994; 10 :323–31. [PubMed]

9.Karakousis CP, Kontzoglou K, Driscoll DL. Resectability of retroperitoneal sarcoma: a matter of surgical technique. Eur J Surg Oncol.1995; 21 :617–22. [PubMed]

10.Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg.1991; 214 :2–10. [PMC free article] [PubMed]

11.Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: Implications for management. J Clin Oncol.1997; 15 :2832–9. [PubMed]

12.Russell WO, Cohen J, Edmonson JH, et al. Staging system for soft tissue sarcoma. Semin Oncol.1981; 8 :156–9. [PubMed]

13.Matsumoto K, Takada M, Okabe H, Ishizawa M. Foci of signal intensities different from fat in well-differentiated liposarcoma and lipoma. Correlation between MR and histological findings. Clin Imaging.2000; 24 :38–43. [PubMed]

14.Sung MS, Kang HS, Suh JS, et al. Myxoid liposarcoma: appearance at MR imaging with histologic correlation. Radiographics.2000; 20 :1007–19. [PubMed]

15.Kransdorf MJ, Bancroft LW, Peterson JJ, Murphey MD, Foster WC, Temple HT. Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology.2002; 224 :99–104. [PubMed]

16.Blum U, Wildanger G, Winfuhr M, et al. Preoperative CT and MR imaging of inferior vena cava leiomyosarcoma. Eur J Radiol.1995; 20 :23–7. [PubMed]

17.Hemant D, Krantikumar R, Amita J, Chawla A, Ranjeet N. Primary leiomyosarcoma of inferior vena cava, a rare entity: Imaging features. Aust Radiol.2001; 45 :448–51.


18.Eilber FC, Eilber KS, Eilber FR. Retroperitoneal sarcomas. Curr Treat Opin Oncol.2000; 1 :274–8. [PubMed]

19.Heslin MJ, Smith JK. Imaging of soft tissue sarcomas. Surg Oncol Clin N Am.1999; 8 :91–107. [PubMed]

20.Varma DG. Imaging of soft tissue sarcomas. Curr Oncol Rep.2000; 2 :487–90. [PubMed]

21.Folpe AL, Lyles RH, Sprouse JT, Conrad EU III, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res.2000; 6 :1279–87. [PubMed]

22.El-Zeftawy H, Heiba SI, Jana S, et al. Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma. Cancer Biother Radiopharm.2001; 16 :37–46. [PubMed]

23.Messa C, Landoni C, Pozzato C, Fazio F. Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms? J Nucl Med.2000; 41 :1702–3. [PubMed]

24.Stoeckle E, Coinbdre JM, Bonvalot S, et al. French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer.2001; 92 :359–68. [PubMed]

25.Mahajan A. The contemporary role of the use of radiation therapy in the management of sarcoma. Surg Clin Oncol N Am.2000; 9 :503–24. [PubMed]

26.Pisters PWT, Ballo MT, Patel SR. Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol.2002; 9 :535–42. [PubMed]

27.Alektiar KM, Hu K, Anderson L, Brennan MF, Harrison LB. High-dose rate intraoperative radiation therapy (HD-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys.2000; 9 :61–5. [PubMed]

28.Marinello P, Montresor E, Iacono C, et al. Long term results of aggressive surgical treatment of primary and recurrent retroperitoneal sarcomas. Chir Ital.2001; 53 :149–57. [PubMed]

29.Karakousis CP, Gerstenbluth R, Kontzglous K, Driscoll DL. Retroperitoneal sarcomas and their management. Arch Surg.1995; 130 :1104–9. [PubMed]

30.Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg.2003; 138 :248. [PubMed]

31.Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg.2004; 239 :244–50. [PMC free article] [PubMed]

32.Gupta AK, Cohan RH, Francis IR, et al. Patterns of recurrent retroperitoneal sarcomas. AJR.2000; 174 :1025–30. [PubMed]

33.Fotiadis C, Zografos GN, Karatzas G, Papchristodoulou A, Sechas MN. Recurrent liposarcomas of the abdomen and retroperitoneum: three case reports. Anticancer Res.2000; 20 :579–83. [PubMed]

34.Cormier JN, Pollock RE. Soft tissue sarcoma. CA: A Cancer Journal for Clinicians.2004; 54 :94–109. [PubMed]

Category: Cancer-2

Similar articles: